Organization
Regional Cancer and Blood Centre, Auckland District Health Board, Auckland, New Zealand
1 abstract
Abstract
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic esophageal and gastroesophageal carcinoma with dysphagia: A single arm phase 2 clinical trial, PALEO.Org: Department of Medical Oncology, Calvary Mater Newcastle, Waratah, Australia, Calvary Mater, Newcastle, Australia, Peter MacCallum Cancer Centre, Melbourne, Australia, Australasian Gastro-Intestinal Trials Group, Sydney, Australia, St. Vincent's Cancer Centre, Fitzroy, Australia,